Mark Ashby
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Hematology top 2%
- Platelet Disorders and Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
- Hematology 16
- Hematopoietic Stem Cell Transplantation 11
- Platelet Disorders and Treatments 7
- Blood groups and transfusion 4
- Acute Myeloid Leukemia Research 3
- Oncology 9
- Polyomavirus and related diseases 4
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Maureen Murphy (1 shared paper)Deborah Keefe (1 shared paper)Mary Kathryn Pierri (1 shared paper)Virginia Paton (1 shared paper)Andrew D. Seidman (1 shared paper)Steven Shak (1 shared paper)Clifford A. Hudis (1 shared paper)Stanford J. Stewart (1 shared paper)
- Journals
- Biology of Blood and Marrow Transplantation (3 papers)Blood (2 papers)Journal of Intellectual Disability Research (2 papers)Journal of Allergy and Clinical Immunology (2 papers)Journal of Vascular and Interventional Radiology (2 papers)
- Partner nations
- United StatesAustraliaSouth Korea
In The Last Decade
Mark Ashby
44 papers receiving 2.9k citations
Mark Ashby's Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 1.1k
- Hematology 407
- Cardiology and Cardiovascular Medicine 739
- Rheumatology 417
- Genetics 259
Countries citing papers authored by Mark Ashby
This map shows the geographic impact of Mark Ashby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ashby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ashby more than expected).
Fields of papers citing papers by Mark Ashby
This network shows the impact of papers produced by Mark Ashby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ashby. The network helps show where Mark Ashby may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Ashby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience Hit paper breakdown → | 2002 | 1190 |
| 2 | Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy Hit paper breakdown → | 2013 | 408 |
| 3 | 2009 | 244 | |
| 4 | 2003 | 152 | |
| 5 | 2000 | 137 | |
| 6 | 2010 | 95 | |
| 7 | 2000 | 72 | |
| 8 | 1995 | 60 | |
| 9 | 2020 | 60 | |
| 10 | 1996 | 59 | |
| 11 | 1998 | 49 | |
| 12 | 1989 | 45 | |
| 13 | 1997 | 43 | |
| 14 | 2012 | 43 | |
| 15 | Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis. | 1987 | 36 |
| 16 | 2020 | 35 | |
| 17 | Bladder irrigation does not prevent haemorrhagic cystitis in bone marrow transplant recipients. | 1991 | 32 |
| 18 | 1997 | 30 | |
| 19 | 1991 | 26 | |
| 20 | Thrombopoietin mobilizes CD34+ cell subsets into peripheral blood and expands multilineage progenitors in bone marrow of cancer patients with normal hematopoiesis. | 1998 | 26 |
About Mark Ashby
Mark Ashby is a scholar working on Hematology, Oncology, Emergency Medical Services, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 45 papers that have together received 3.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (11 papers), Platelet Disorders and Treatments (7 papers), Polyomavirus and related diseases (4 papers), Blood groups and transfusion (4 papers), Central Venous Catheters and Hemodialysis (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Acute Myeloid Leukemia Research (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). The work is most often cited by research in Oncology (1.1k citations), Hematology (407 citations), Cardiology and Cardiovascular Medicine (739 citations), Rheumatology (417 citations) and Genetics (259 citations). Mark Ashby has collaborated with scholars based in United States, Australia and South Korea. Frequent co-authors include Maureen Murphy, Deborah Keefe, Mary Kathryn Pierri, Virginia Paton, Andrew D. Seidman, Steven Shak, Clifford A. Hudis, Stanford J. Stewart, Mark Kozloff and Fairooz F. Kabbinavar. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Blood, Journal of Intellectual Disability Research, Journal of Allergy and Clinical Immunology and Journal of Vascular and Interventional Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.